The abstract is read at the publisher; the summary is JClub's.
A nanoscale calcified bone-on-a-chip links mineralized collagen hydrogels to osteocyte-like osteoblast-lineage changes and RANKL/OPG-driven osteoclastogenesis without exogenous growth factors.
- Why it matters: Recreating bone’s spatial cell interactions and mineralized microenvironment in vitro is difficult, limiting faithful modeling of remodeling, drug response, and tumor-bone crosstalk.
- What they did: The platform uses cell-laden collagen hydrogels with nanoscale mineralization to form a multicellular niche, driving immune-cell differentiation into osteoclasts via endogenous RANKL/OPG signaling and enabling calcified resorption.
- The result: Mineralized niche-driven osteoclastogenesis produced greater osteoclast differentiation than conventional RANKL and M-CSF stimulation, reproduced differential anti-resorptive drug responses, and supported vascularized tumor-bone interaction patterns.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.